Point-of-care diagnostic testing for hemoglobin, glucose, and blood cell analysis
HemoCue manufactures portable diagnostic devices for clinical settings, with a tech stack centered on Java/Spring and React for cloud and web interfaces deployed on AWS. The hiring mix is heavily sales-driven (14 of 19 active roles), indicating aggressive geographic and channel expansion—particularly into Southeast Asia and alternate care sites—while the engineering footprint remains minimal, suggesting product and infrastructure are mature. Pain points cluster around production capacity, channel partner onboarding, and cost-efficient scaling, revealing a manufacturing company in growth mode rather than platform reinvention.
HemoCue is a publicly held Swedish diagnostics manufacturer founded in 1982, now part of Danaher. The company produces point-of-care testing devices for hemoglobin, glucose, HbA1c, and white blood cell analysis, sold into clinical settings and hospital networks globally. Operations span manufacturing, quality, sales, and engineering across Sweden, Indonesia, the United States, and India. Current strategic focus centers on regional volume growth, profitability improvement in existing accounts, and expansion into alternate care sites and Southeast Asian markets.
Java, Spring Boot, React, TypeScript, PostgreSQL, and AWS. Salesforce and Microsoft Office round out the enterprise software footprint.
Point-of-care testing for hemoglobin, glucose, HbA1c, and total and differential white blood cell count, deployed across clinical settings globally.
Other companies in the same industry, closest in size